Omeros | Profitto Lordo Sulle Vendite



Gross Profit On Sales Cambiamento Data
Adma Biologics USD 63.33M 3.67M 2024-12
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Cytokinetics -160545000 81.19M 2024-09
Dynavax Technologies USD 54.4M 4.23M 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
Insmed USD 71.54M 6.75M 2025-03
Knight Therapeutics CAD 45.02M 2.32M 2024-09
MacroGenics USD 13.86M 94.98M 2024-12
Pacira USD 134.62M 12.75M 2025-03
Pfizer USD 11.12B 987M 2025-03
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
United Therapeutics USD 701.9M 41.9M 2025-03
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



Omeros Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.